Study Evaluating Venlafaxine ER in Recurrent Depression

Phase 4

Completed

• Conditions: Depressive Disorder, Major; Recurrence

• Registration Number: NCT00046020
• Lead Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer

Brief Summary

The purpose of this study is to review the long-term comparative efficacy of venlafaxine ER in achieving and sustaining remission (wellness) in patients with recurrent major depression

Detailed Description

Not available

Study Timeline

• Study Start: 2000-08
• Study First Submitted: 2002-09-18
• Study First Submitted QC: 2002-09-18
• Study First Posted: 2002-09-19
• Primary Completion: 2005-10
• Study Completion: 2005-10
• Status Verified: 2009-08
• Last Update Submitted: 2009-08-13
• Last Update Posted: 2009-08-14

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 1096

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: Not specified